TRADING HALTED

Antibe Therapeutics Inc(Pre-Merger) ATE-CA:Toronto Stock Exchange

*Data is delayed | Exchange | CAD
Last | 05/02/24 EDT
0.295UNCH (UNCH)
52 week range
0.15 - 1.23
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.295
  • 52 Week High1.23
  • 52 Week High Date11/09/23
  • 52 Week Low0.15
  • 52 Week Low Date04/01/24

Key Stats

  • Market Cap11.45M
  • Shares Out53.01M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-0.26
  • YTD % Change-68.28

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.295
  • 52 Week High1.23
  • 52 Week High Date11/09/23
  • 52 Week Low0.15
  • 52 Week Low Date04/01/24
  • Market Cap11.45M
  • Shares Out53.01M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-0.26
  • YTD % Change-68.28

RATIOS/PROFITABILITY

  • EPS (TTM)-0.35
  • P/E (TTM)-0.85
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Antibe Therapeutics Inc(Pre-Merger)

 

Profile

MORE
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs...
Walter Macnee
Vice Chairman of the Board
Robert Hoffman CPA
Independent Chairman of the Board
Daniel Legault J.D.
President, Chief Executive Officer, Secretary, Director
Scott Curtis
Chief Operating Officer
Alain Wilson
Chief Financial Officer
Address
15 Prince Arthur Avenue
Toronto, ON
M5R 1B2
Canada

Top Peers

SYMBOLLASTCHG%CHG
RVX
Resverlogix Corp
0.06UNCHUNCH
EDSA
Edesa Biotech Inc
4.54-0.01-0.33%
AEZS
Aeterna Zentaris Inc
7.84-0.20-2.49%
KTRA
Kintara Therapeutics Inc
0.1513-0.0059-3.7532%
PRTG
Portage Biotech Inc
0.271+0.0111+4.2709%